Key Highlights
- Partnership with Intermountain Children’s Health aims to fast-track diagnosis of genetic diseases in kids using AI-powered sequencing.
- Innovative whole genome sequencing service offered by Broad Clinical Labs and Fabric Genomics to revolutionize pediatric healthcare.
- Critical support for infants with congenital heart disease (CHD), enhancing diagnostic accuracy and personalized treatment plans.
Source: Business Wire
Notable Quotes
- “Whole genome sequencing … is a game-changer for the children and families we serve. This partnership allows us to quickly and cost-effectively access top-tier clinical-grade genome sequencing and reporting, more accurate diagnoses for these infants, and the ability to reanalyze the data, all of which ultimately will improve outcomes and enhance the quality of care we deliver to children,” – Dr. Martin Tristani-Firouzi, Pediatric Cardiologist at University of Utah Health and Intermountain Primary Children’s Hospital
- “Our collaboration with Intermountain Primary Children’s Hospital and Broad Clinical Labs is a model for genomic medicine within pediatric healthcare,” – Martin Reese, PhD, Co-Founder and CEO at Fabric Genomics
SoHC's Take
This partnership represents a significant leap forward in the fight against genetic diseases in children, showcasing the power of combining cutting-edge AI technologies with the expertise of leading healthcare institutions. By enabling faster, more accurate diagnoses and personalized treatment plans, Fabric Genomics and Intermountain Children’s Health are setting a new standard in pediatric healthcare. Their collaborative effort not only underscores the importance of innovation in medical diagnostics but also highlights the potential of AI in transforming patient care. As this partnership unfolds, it promises to offer new hope to families and children facing genetic health challenges, making it a pivotal moment in the journey towards more effective and personalized healthcare solutions.
